Chemotherapy: a double-edged sword in cancer treatment

N Behranvand, F Nasri, R Zolfaghari Emameh… - Cancer immunology …, 2022 - Springer
Chemotherapy is a well-known and effective treatment for different cancers; unfortunately, it
has not been as efficient in the eradication of all cancer cells as been expected. The …

The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment

D Laha, R Grant, P Mishra, N Nilubol - Frontiers in immunology, 2021 - frontiersin.org
The tumor microenvironment (TME) is an intricate system within solid neoplasms. In this
review, we aim to provide an updated insight into the TME with a focus on the effects of …

Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold

DW Vredevoogd, T Kuilman, MA Ligtenberg… - Cell, 2019 - cell.com
New opportunities are needed to increase immune checkpoint blockade (ICB) benefit.
Whereas the interferon (IFN) γ pathway harbors both ICB resistance factors and therapeutic …

Nutrigenomics of extra‐virgin olive oil: A review

M Piroddi, A Albini, R Fabiani, L Giovannelli… - Biofactors, 2017 - Wiley Online Library
Nutrigenomics data on the functional components of olive oil are still sparse, but rapidly
increasing. Olive oil is the main source of fat and health‐promoting component of the …

[HTML][HTML] TNF receptors: signaling pathways and contribution to renal dysfunction

RS Al-Lamki, TN Mayadas - Kidney international, 2015 - Elsevier
Tumor necrosis factor (TNF), initially reported to induce tumor cell apoptosis and cachexia, is
now considered a central mediator of a broad range of biological activities from cell …

The effects of obesity on anti-cancer immunity and cancer immunotherapy

MJ Woodall, S Neumann, K Campbell, ST Pattison… - Cancers, 2020 - mdpi.com
Cancer is one of the leading causes of morbidity and mortality worldwide. Traditional
treatments include surgery, chemotherapy and radiation therapy, and more recently targeted …

Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy

X Wei, L Liu, X Li, Y Wang, X Guo, J Zhao… - Journal of Controlled …, 2019 - Elsevier
Abstract Tumor-associated macrophage (TAM)-related immunotherapy is a greatly
promising strategy that involves altering the immunosuppressive tumor microenvironment …

TNF receptor 2 makes tumor necrosis factor a friend of tumors

Y Sheng, F Li, Z Qin - Frontiers in immunology, 2018 - frontiersin.org
Tumor necrosis factor (TNF) is widely accepted as a tumor-suppressive cytokine via its
ubiquitous receptor TNF receptor 1 (TNFR1). The other receptor, TNFR2, is not only …

Cooperation between angiogenesis, vasculogenesis, chemotaxis, and coagulation in breast cancer metastases development: pathophysiological point of view

E Zarychta, B Ruszkowska-Ciastek - Biomedicines, 2022 - mdpi.com
Simple Summary Breast cancer is one of the main causes of morbidity and mortality in
women. Early breast cancer has a relatively good prognosis, in contrast to metastatic …

[HTML][HTML] The diverse roles of the TNF axis in cancer progression and metastasis

B Ham, MC Fernandez, Z D'costa… - Trends in cancer …, 2016 - ncbi.nlm.nih.gov
Metastasis is a multi-step process that ultimately depends on the ability of disseminating
cancer cells to establish favorable communications with their microenvironment. The tumor …